نتایج جستجو برای: releasing hormone antagonist

تعداد نتایج: 213193  

Journal: :FEBS letters 2005
Matthew J Mahon Masako Shimada

Parathyroid hormone (PTH) binds to its receptor (PTH 1 receptor, PTH1R) and activates multiple pathways. The PTH1R, a class b GPCR, contains consensus calmodulin-binding motifs. The PTH1R cytoplasmic tail interacts with calmodulin in a calcium-dependent manner via the basic 1-5-8-14 motif. Calcium-dependent calmodulin interactions with the cytoplasmic tails of receptors for PTH 2, vasoactive in...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2014
Yong Jie Qin Sun On Chan Kelvin Kam Lung Chong Benjamin Fuk Loi Li Tsz Kin Ng Yolanda Wong Ying Yip Haoyu Chen Mingzhi Zhang Norman L Block Herman S Cheung Andrew V Schally Chi Pui Pang

Disruptions in immunity and occurrence of inflammation cause many eye diseases. The growth hormone-releasing hormone-growth hormone-insulin-like growth factor-1 (GHRH-GH-IGF1) axis exerts regulatory effects on the immune system. Its involvement in ocular inflammation remains to be investigated. Here we studied this signaling in endotoxin-induced uveitis (EIU) generated by LPS. The increase in G...

Journal: :acta medica iranica 0
zohreh karamizadeh department of pediatric endocrinology, student research center, shiraz university of medical sciences, shiraz, iran. mahmoodreza tabebordbar department of pediatric endocrinology, student research center, shiraz university of medical sciences, shiraz, iran. forough saki department of pediatric endocrinology, student research center, shiraz university of medical sciences, shiraz, iran. hamdollah karamifar department of pediatric endocrinology, student research center, shiraz university of medical sciences, shiraz, iran. gholamhossein amirhakimi department of pediatric endocrinology, student research center, shiraz university of medical sciences, shiraz, iran.

treatment of central precocious puberty (cpp) is the administration of gnrh analogs. metabolic syndrome comprised metabolic disturbances that confer increased risk of (cvd) diabetes mellitus (dm) and cardiovascular disease. this study is a longitudinal prospective study in pediatric endocrinology clinic. 30 non-obese children with idiopathic cpp were involved. total body weight, height, blood p...

Journal: :Oncology 2009
Oscar B Goodman

The recent US Food and Drug Administration (FDA) approval of degarelix, a luteinizing hormone-releasing hormone (LHRH) antagonist, has renewed interest in this class of drugs as a prostate cancer therapy. Approval was based on a prospective phase III trial of 610 patients randomized to one of two dosing schedules of degarelix, or standard-of-care monthly leuprolide acetate monotherapy, with ini...

Journal: :journal of agricultural science and technology 2014
m. r. kalbassi r. lorestani j. g. marammazi

the main objective of this study was assessment of hormonal treatments effects on sperm quality improvement in barbus sharpeyi. results showed differences in effects of treatments with lhrha2, lhrha2 combined with a dopamine antagonist (met), and cpe (carp pituitary extract) on parameters of sperm volume, motility, spermatocrit, biochemical indices of seminal plasma and sperm efficiency on arti...

Journal: :iranian journal of veterinary research 2014
gh. h. farjah t. peirouvi b. heshmatian m. yasami m. a. dolatkhah

gonadotropin-releasing hormone (gnrh) has neuromodulatory roles in central and peripheral nervous systems. the purpose of this study is to evaluate the effect of gnrh analog (buserelin) on peripheral nerve regeneration. forty adult male rats were divided into buserelin-treated, normal saline, sham surgery, and castrated + buserelin groups. the left sciatic nerve was crushed by a fine forceps an...

Journal: :international journal of endocrinology and metabolism 0
kobra shiasi arani department of pediatric endocrinology, research center for biochemistry and nutrition in metabolic disorders, kashan university of medical sciences, kashan, ir iran; department of pediatric endocrinology, research center for biochemistry and nutrition in metabolic disorders, kashan university of medical sciences, kashan, ir iran. tel: +98-3155580190, fax: +98-3155548900 fatemeh heidari nekoei-hedayati therapeutic educational center, qom university of medical sciences, qom, ir iran

results from 110 subjects with cpp, 46 girls (41.8%) were considered as intervention and 64 (58.2%) as control groups. the mean age at initial visit was 7.46 ± 1.03 years. the bmi standard deviation scores in both groups was not significantly different at sixth and 12th months of treatment compared with baseline (p = 0.257 and p = 0.839, respectively). the prevalence of obesity was not signific...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید